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Abstract
Background: Lung cancer survivors are more likely to develop colorectal and stomach cancer than the general
population. However, little is known about the current status of gastrointestinal cancer screening practices and
related factors among lung cancer survivors.
Methods: We enrolled 829 disease-free lung cancer survivors ≥40 years of age, who had been treated at two
hospitals from 2001 to 2006. The patients completed a questionnaire that included stomach and colorectal
cancer screening after lung cancer treatment, as well as other sociodemographic variables.
Results: Among lung cancer survivors, correlations with stomach and colorectal screening recommendations
were 22.7 and 25.8%, respectively. Of these, 40.7% reported receiving physician advice to screen for second primary
cancer (SPC). Those who were recommended for further screening for other cancers were more likely to receive
stomach cancer screening [adjusted odds ratios (aOR) = 1.63, 95% confidence interval (CI), 1.16–2.30] and colorectal
cancer screening [aOR = 1.37, 95% CI, 0.99–1.90]. Less-educated lung cancer survivors were less likely to have
stomach and colorectal cancer screenings.
Conclusions: Lack of a physician’s advice for SPC screening and lower educational status had negative impact
on the gastrointestinal cancer screening rates of lung cancer survivors.
Keywords: Colorectal cancer screening, Stomach cancer screening, Lung cancer survivor, Physician
recommendation
Background
Although advanced stage lung cancer has a poor
prognosis, [1] early stage lung cancer can be treated
with surgical resection, resulting in an improved
prognosis [2, 3]. Recently, the US Preventive Services
Task Force (USPSTF) recommended annual screening
for lung cancer, using low dose computed tomography
(CT) for individuals at a high risk for this disorder
[4]. Furthermore, the clinical practice of low dose CT
scanning as an early detection tool, as well as
advances in cancer treatment, could lead to an
increased number of lung cancer survivors [3, 4].
Previous studies have reported that lung cancer
patients were at an increased risk for second primary
cancers (SPCs) [5, 6]. For second primary gastrointes-
tinal cancers, a recent study reported that early stage
lung cancer patients had approximately a 40% increased
risk of colorectal and stomach cancer than the general
population [6]. The Global Burden of Disease Study in
2017 has demonstrated that colorectal cancer and stom-
ach cancer are ranked within global top 5 cancers, [7]
colorectal cancer screening and stomach cancer screen-
ing are introduced in several countries [8–10]. Cancer
survivors were recommended to adhere routine age- and
sex-appropriate cancer screening guideline in general
population [11–13]. Especially, as colorectal cancer is
* Correspondence: lawyun@snu.ac.kr
†Equal contributors
1Department of Biomedical Science, Seoul National University College of
Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Republic of Korea
2Department of Family Medicine, Seoul National University College of
Medicine, Seoul, Republic of Korea
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Park et al. BMC Cancer  (2017) 17:600 
DOI 10.1186/s12885-017-3583-z
the most common cancer, and stomach cancer remains
the second common cancer in Korea, [14] continued
surveillance program regarding gastrointestinal cancer
screening for Korean lung cancer survivors will be
needed. However, little is known about the gastrointes-
tinal cancer screening practices in lung cancer survivors.
The aim of our survey was to determine the patterns of
screening for colorectal and stomach cancer screening
and related factors in lung cancer survivors who were
disease free in Korea. We hypothesized that not only
low social-demographic status but also lack of physi-
cians’ advice for SPC screening or patients’ mispercep-
tion about their risk of SPC would have negative
impacts on the gastrointestinal cancer screening behav-
iors in lung cancer survivors.
Methods
Study participants
We identified 2049 patients who had been treated for
lung cancer in two hospitals in the Republic of Korea,
between 2001 and 2006. We performed a cross-sectional
survey of lung cancer survivors in 2007. Eligible subjects
were contacted by telephone, and those who agreed to
participate were surveyed with questionnaires at home
or at the clinic. Lung cancer survivors who were treated
with curative surgery and had no other history of cancer
were eligible to participate. The institutional review
board of the National Cancer Center, Korea reviewed
and approved the protocol of our study. Details of the
study design have been previously described [15].
Definition of appropriate uptake of gastrointestinal
cancer screening
For stomach cancer screening, Korean National Cancer
Screening Program (KNCSP) [8] recommended gastros-
copy or double-contrast upper gastrointestinal series
every 2 years for general population ≥ 40 years of age,
and the Japanese government introduced gastroscopy as
a national screening program [9, 16]. For early detection
of colorectal cancer, annual FOBT was recommended
for those ≥50 years of age by the KNCSP [8] and by the
USPSTF. The American Cancer Society (ACS) has
recommended sigmoidoscopy every 5 years, a double-
contrast barium enema every 5 years, or a colonoscopy
every 10 years [10, 17, 18]. However, colorectal screening
guidelines for the general population could underesti-
mate the actual needs of cancer survivors. One previous
study reported that for cancer survivors aged 40-years-
old, colonoscopy every 5 years might be an economically
feasible strategy [19]. As a baseline analysis of colorectal
cancer screening, we considered all the above mentioned
recommendations to be compliant with colorectal
screening among lung cancer survivors ≥40 years of age.
We also performed sensitivity analysis with subject
≥50 years of age, using the above cancer screening
recommendations.
To assess the practices of stomach and colorectal
cancer screening after cancer treatment, lung cancer sur-
vivors were asked the following questions (Additional
file 1): 1) “When did you receive a gastroscopy or
double-contrast upper gastrointestinal series recently?”
with responses of “no,” “≤ 2 years ago,” “2–5 years ago,”
and “>5 years ago”; 2) “What kind of colorectal cancer
screening test did you receive?” with responses of “no,”
“fecal occult blood test (FOBT),” “double-contrast
barium enema,” “sigmoidoscopy,” and “colonoscopy”;
and 3) “If you receive a colorectal cancer screening,
when did you receive the last colorectal cancer screening
test?” with responses of “<1 year ago,” “1–5 years ago,”
“5–10 years ago,” and “>10 years ago.”
Independent variables
Lung cancer survivors were asked to approximate their
risk of SPC compared with cancer risk in general popu-
lation, with the responses being lower, similar, or higher.
The survey also included question about receiving a
physicians’ recommendation to screen for SPC after lung
cancer treatment. In addition, participants were asked to
answer questions about age, highest educational attain-
ment, ethnicity, income, health behavior (physical activ-
ity, smoking, alcohol consumption, height and weight),
and health-related quality of life (the European
Organization for Research and Treatment of Cancer
Quality of Life Questionnaire Core-30 item and lung
cancer module, Hospital Anxiety and Depression Scale
and Posttraumatic Growth Inventory) through our
systematically organized questionnaire. From the
hospital cancer registries, we gathered information about
clinical characteristics such as ages at cancer diagnosis,
tumor stage, type of surgery, history of chemotherapy or
radiotherapy, and recurrence.
Statistical analysis
Descriptive statistics were reported for each response.
Among subjects, those who received gastroscopy or
double-contrast upper gastrointestinal series within
2 years were defined as lung cancer survivors with ap-
propriate stomach cancer screening [8]. Lung cancer
survivors who received FOBT within 1 year, a double-
contrast barium enema within 5 years, sigmoidoscopy
within 5 years, or colonoscopy within 10 years were
defined as receiving appropriate colorectal cancer
screening [10, 17, 18]. We then calculated the occur-
rences of lung cancer survivors who had second gastro-
intestinal cancer screening according to these guidelines.
Adjusted odds ratios were determined by logistic
regression analysis, main independent variable being
physicians’ advice for SPC screening, perception of
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second cancer risk, highest educational attainment, and
family income adjusted for age, stage, marital status,
smoking status, and alcohol consumption. We also per-
formed sensitivity analysis with lung cancer survivors
≥50 years of age. All statistical analyses were two-sided
and performed using STATA 10.0 software (Stata Corp.,
College Station, TX, USA). The significance level was set
at P < 0.05.
Results
Among the potentially eligible population, 126 (6.1%) had
died, 290 (14.2%) could not be contacted in spite of mul-
tiple attempts. Excluded from this study were patients
whose cancer had recurred at the time of the survey. All
participants provided written informed consent. Of the
1633 contacted patients, 727 (35.5%) refused to partici-
pate, and 906 (44.2%) consented to participate. Among
the respondents, 76 patients had cancer which had
recurred, or were receiving cancer therapy at the time.
One subject <40 years of age was excluded. The analysis
included 829 lung cancer survivors ≥40 years of age.
The mean age of 829 lung cancer survivors was
62.9 years (40–78 years). Of these, 44.2% had no more
than a 6th grade education, and 63.1% was diagnosed as
stage I lung cancer. Among disease-free lung cancer sur-
vivors, 40.7% reported receiving physician advice to
screen for other cancers. About one out of ten reported
a perception that they had a lower risk of other cancers
than the general population, and 60.1% believed that
they had a higher risk of other cancers than general
population (Table 1). When we compared the charac-
teristics of the participants and non-participants
among1633 contacted patients, responders were more
likely to be men and to live in metropolitan areas than
non-participants (Additional file 2: Table S1).
The proportions for receiving appropriate stomach
cancer screening and colorectal cancer screening were
22.7 and 26.1%, respectively (Fig. 1). Both male and
female lung cancer survivors showed similar trends of
SPC cancer screening.
Factors related to the uptake of stomach cancer
screening for lung cancer survivors
Lung cancer survivors who recalled being informed
about the need for SPC screening were more likely to
have stomach cancer screening in multivariate-adjusted
analysis [adjusted OR (aOR) = 1.63, 95% CI, 1.16–2.30],
and these associations were greater among male patients
(Table 2). When we assessed compliance of stomach
cancer screening practices by monthly household
income and perception of SPC risk, there were no
significant differences among the groups. Lung can-
cer survivors with the most education (≥ 12 years)
were more likely to have stomach cancer screening
(aOR = 1.72, 95% CI, 1.00–2.96), especially for male
patients (aOR 1.87, 95% CI, 1.00–3.51). Multivariate
analysis of patients ≥50 years of age showed associa-
tions between the above factors with uptake of stom-
ach cancer screening that were similar to those of
patients ≥40 years of age.
Factors related to the uptake of colorectal cancer
screening for lung cancer survivors
Participant’s reporting to receive a physicians’ advice to
screen for other cancers was positively associated with
receiving colorectal cancer screening in both age-
adjusted analysis (aOR = 1.52; 95% CI, 1.09–2.12) and
multivariate analysis (aOR = 1.37, 95% CI, 0.99–1.91;
Table 3). Self-perception of SPC risk was not
Table 1 Demographic and clinical characteristics of disease-free
lung cancer survivors
Characteristics N %
Age, years (mean) (62.9)
40–49 58 7.0
50–64 379 45.7






Unmarried, divorced, or bereaved 66 9.3
Level of Education
≤ 6 years 229 44.2
7–11 years 389 28.6
≥ 12 years 210 27.2
Monthly household income, $(US)
≥ 3000 225 27.2
1000–2999 363 43.8





Receiving physician advice to screen for SPC
Yes 337 40.7
No 491 59.3
Self-perception of the SPC risk
Lower than the general population 77 9.3
Same as the general population 253 30.6
Higher than the general population 496 60.1
SPC second primary cancer
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significantly associated with colorectal screening
practices. Less-educated patients were less likely to have
colorectal cancer screening (aOR = 1.76, 95% CI,
1.05–2.96). Family income was also significantly asso-
ciated with colorectal cancer screening compliance
among female lung cancer survivors. Compared with
family income less than $1000/month, female lung cancer
survivors with a higher income (≥ $3000/month) were
more likely to undergo a colorectal cancer screening
(aOR = 5.09, 95% CI, 1.28–20.14).
When we performed a sensitivity analysis with subjects
≥50 years of age, male lung cancer survivors who
received a physicians’ advice of screening for second
cancers were more likely to have a colorectal cancer
screening (aOR = 1.48, 95%CI, 1.00–2.18).
Discussion
Our study showed that colorectal and gastric cancer
screening practices among lung cancer survivors was
less than optimal. In addition, half of these patients did
not recall receiving advice from their physicians about
SPC screening. Lack of a physicians’ advice for SPC
screening and lower educational status might have nega-
tive impact on the gastrointestinal cancer screening rates
of lung cancer survivors.
Because lung cancer survivors have an increased risk
of colorectal and stomach cancer development, [5, 6]
Fig. 1 Percentage of lung cancer survivors who received stomacha
and colorectalb cancer screening. aAmong lung cancer survivors,
those who received gastroscopy or double-contrast upper
gastrointestinal series within 2 years were defined as lung cancer
survivors with appropriate stomach cancer screening. bLung cancer
survivors who received FOBT within 1 year, a double-contrast barium
enema within 5 years, sigmoidoscopy within 5 years, or colonoscopy
within 10 years were defined as receiving appropriate colorectal
cancer screening
Table 2 Factors related to the uptake of stomach cancer screeninga for lung cancer survivors













Receiving physician advice to screen for SPC
No 19.8 1.0 1.0 19.5 1.0 1.0 20.8 1.0 1.0
Yes 26.7 1.52 (1.09–2.11) 1.61 (1.14–2.26) 27.4 1.59 (1.09–2.32) 1.73 (1.17–2.56) 24.7 1.32 (0.66–2.63) 1.30 (0.61–2.80)
Perceived risk of SPC in lung cancer survivors
Lower than general
population (GP)
20.8 1.0 1.0 22.9 1.0 1.0 12.5 1.0 1.0
Same or higher
than GP
22.6 1.07 (0.60–1.91) 1.16 (0.63–2.13) 22.4 0.95 (0.51–1.79) 0.97 (0.50–1.88) 23.0 1.89 (0.40–8.92) 2.34 (0.44–12.43)
Monthly household income, ($US)
< 1000 19.6 1.0 1.0 18.9 1.0 1.0 22.0 1.0 1.0
1000–2999 21.8 1.11 (0.73–1.67) 1.03 (0.66–1.59) 22.5 1.20 (0.75–1.92) 1.06 (0.64–1.73) 19.5 0.79 (0.31–1.97) 1.10 (0.33–3.05)
≥ 3000 27.4 1.44 (0.91–2.23) 1.48 (0.94–2.32) 27.2 1.50 (0.88–2.56) 1.20 (0.66–1.71) 28.1 1.24 (0.48–3.21) 1.34 (0.37–4.95)
Education
≤ 6 years 17.5 1.0 1.0 14.6 1.0 1.0 24.6 1.0 1.0
7–11 years 22.7 1.33 (0.86–2.06) 1.40 (0.88–2.22) 24.7 1.88 (1.11–3.19) 1.93 (1.11–3.35) 15.9 0.51 (0.22–1.20) 0.46 (0.17–1.24)
≥ 12 years 28.6 1.78 (1.10–2.87) 1.72 (1.00–2.96) 26.9 2.09 (1.18–3.72) 1.87 (1.00–3.51) 35.9 1.43 (0.56–3.64) 1.34 (0.40–4.48)
OR odds ratio, CI confidence interval, SPC second primary cancer
aSubjects who received gastroscopy or double-contrast upper gastrointestinal series within 2 years were defined as lung cancer survivors with appropriate
stomach cancer screening
bAdjusted for age, stage, marital status, education, family income status, smoking status, alcohol consumption, receiving recommendation for other cancer
screening, and the perception of secondary cancer risks
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following the recommendations of gastrointestinal can-
cer screening for the average risk population should be
needed at a minimum. However, our study showed that
less than 30% of disease-free lung cancer survivors
adhered to these colorectal and stomach screening
recommendations. Several previous studies [20, 21] and
one recent meta-analysis [22] reported that many cancer
survivors did not receive screening tests recommended
for the detection of SPCs, although cancer survivors
received more frequent screening for cancers than non-
cancer controls. These findings emphasized the need to
identify effective methods to increase cancer screening
practices for cancer survivors. Several interventions,
such as reminders, small media, and face-to-face educa-
tion have been reported to increase screening rates in
general population [23]. However, little is known about
whether these interventions of increasing appropriate
knowledge could lead to increased SPC screening among
cancer survivors. Furthermore, an interventional trial
using educational materials to increase knowledge about
SPC screening reported no increase in actual cancer
screening for cancer survivors [24].
The present study showed that a lack of recommenda-
tion for SPC screening from physicians might have a
negative impact on the colorectal and stomach cancer
screening behaviors among lung cancer survivors.
Similarly, a previous study reported that cervical cancer
survivors who received, to whom their health care pro-
viders had recommended other cancer screening, were
more likely to receive breast cancer screening [25]. After
experiencing cancer, survivors usually have high levels of
trust in their physicians, [26, 27] and physicians’ advice
for screening might provide good opportunities to
improve SPC screening behaviors.
Only 40.7% of disease-free lung cancer survivors, how-
ever, recalled being informed about the need for SPC
screening or referred for such tests. Together with the
results of previous studies, our results suggests that
more information and training regarding appropriate
cancer screening guidelines for cancer survivors will be
needed for health care providers. Because there were few
guidelines regarding such specific SPC screening, a
feasible step should be started with increasing cancer
survivors’ compliance to cancer screening guidelines for
the general population. If physicians’ recommendation
for SPC screening would be incorporated in the
survivorship care plan, it might foster physician commu-
nication and shared care in monitoring SPC screening
for cancer survivors.
We also found educational disparities in stomach and
colorectal cancer screening among lung cancer survi-
vors, and found income disparities in colorectal cancer
Table 3 Factors related to the uptake of colorectal cancer screeninga for lung cancer survivors













Receiving physician advice to screen for SPC
No 23.3 1.0 1.0 22.9 1.0 1.0 25.0 1.0 1.0
Yes 29.0 1.52 (1.09–2.12) 1.37 (0.99–1.91) 29.2 1.38 (0.96–1.99) 1.46 (1.00–2.12) 28.2 1.30 (0.68–2.48) 1.14 (0.53–2.48)
Perceived risk of SPC in lung cancer survivors
Lower than general
population (GP)
21.6 1.0 1.0 22.0 1.0 1.0 20.0 1.0 1.0
Same or higher
than GP
25.9 1.07 (0.60–1.91) 1.14 (0.65–2.03) 25.7 1.16 (0.62–2.16) 1.13 (0.59–2.15) 26.6 1.08 (0.32–3.62) 1.37 (0.33–5.63)
Monthly household income, $(US)
< 1000 24.2 1.0 1.0 24.6 1.0 1.0 22.5 1.0 1.0
1000–2999 21.6 1.96 (0.73–1.67) 0.73 (0.48–1.12) 22.5 0.85 (0.55–1.32) 0.68 (0.43–1.10) 17.9 0.88 (0.44–4.48) 1.51 (0.47–4.88)
≥ 3000 34.5 1.45 (0.91–2.30) 1.22 (0.74–2.02) 32.2 1.47 (0.89–2.41) 1.02 (0.58–1.82) 40.7 2.98 (1.18–7.53) 5.09 (1.28–20.14)
Education
≤ 6 years 20.8 1.0 1.0 17.8 1.0 1.0 28.6 1.0 1.0
7–11 years 25.3 1.33 (0.86–2.05) 1.34 (0.87–2.09) 27.4 1.73 (1.05–2.84) 1.91 (1.13–3.23) 17.7 0.56 (0.25–1.27) 0.34 (0.12–0.94)
≥ 12 years 33.2 1.78 (1.11–2.88) 1.76 (1.05–2.96) 30.3 2.14 (1.25–3.68) 1.87 (1.02–3.41) 48.3 2.75 (1.12–6.78) 1.35 (0.40–4.48)
OR odds ratio, CI confidence interval, SPC second primary cancer
aSubjects who received FOBT within 1 year, a double-contrast barium enema within 5 years, sigmoidoscopy within 5 years, or colonoscopy within 10 years were
defined as receiving appropriate colorectal cancer screening
bAdjusted for age, stage, marital status, education, family income status, smoking status, alcohol consumption, receiving recommendation for other cancer
screening, and perception of secondary cancer risks
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screening among female subjects. Although several stud-
ies have reported educational and income disparities in
cancer screening practices among the general popula-
tion, [28, 29] little is known about these disparities
among cancer survivors. In order to provide equal access
to SPC screening services for cancer survivors, further
collaborative efforts by policy makers, third party payers,
and healthcare providers are needed. Several previous
studied have suggested that educational disparity on
receipt of cancer screening might be mediated by the
role of health literacy [30, 31]. Further study for low-
educated cancer patients will be needed to increase
appropriate knowledge and attitude for SPC screening
during or after the cancer treatment periods. Further-
more, because cancer survivors are more financially
vulnerable, [32, 33] decreasing economic barrier for SPC
screening should be considered.
Our study had several limitations. First, we used self-
reported survey to assess the cancer screening compli-
ance and physicians’ advice for SPC screening, which
were not confirmed by medical record reviews or claims.
Second, the response rate was only 44.2%. As partici-
pants could have been more likely to have preventive
health behaviors than non-participants, our estimates of
SPC screening practices among lung cancer survivors
might therefore have been overestimated. Third, our
study population consisted of Korean lung cancer
survivors and stomach cancer screening is not recom-
mended in western countries, which may limit the
generalizability of our results. Although recent study has
demonstrated that those who received an upper endos-
copy were less likely to die from stomach cancer within
the Korean national cancer screening program, [34] and
cancer survivors were usually recommended to receive
routine cancer screening guideline which is recom-
mended in general population, [11–13] further evidences
will be needed among other ethnicities.
Conclusion
The present study showed that only a quarter of lung
cancer survivors included were meeting existing guide-
lines for second primary cancer screening, particularly
gastric and colorectal cancer. Physician must more
proactive in communicating the need for screening and
referring patients for such screening tests. In addition,
further public policy will be needed to decrease
educational disparities in SPC screening practices.
Additional files
Additional file 1: Questionnaires about uptake of gastrointestinal cancer
screening among lung cancer survivors. (DOCX 14 kb)
Additional file 2: Table S1. Characteristics of the participants and
non-participants. (DOC 27 kb)
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